Summary of Biomarker Expression in Benign Samples. The STT and LTT groups exhibit significant changes in biomarker expression compared to the nontreatment group, measured on a two-... by Jinho Lee (587173)

Subjects:

Data from: <b>Selection and genetic variation in plasticity drive age-related decreases in among-individual behavioural correlations</b> by Chang Seok Han (21814121)

“…The similarity of age-related changes in among-individual and genetic correlations resulted from the absence of short-term permanent environmental correlations. …”

Each square gives extinction probability p (AB) or median population change d (CD) for 100 simulations at . by Alexandra M. Campbell (3284094)

Morphologic changes after dihydrotestosterone (DHT) treatment.1A: Diffuse lobular atrophy (20x). by Jinho Lee (587173)

Subjects:

Narrow- and broad-band spectral changes after hemispherotomy in an awake representative patient, displaying marked electroencephalography (EEG) slowing of the isolated cortex. by Michele Angelo Colombo (22446342)

Distribution of population at final time (left) and change in mean MSI at final time (right) from simulations across 1000 parameter sets when weevils are absent (red) and with weev... by Alexandra M. Campbell (3284094)

Change in STAI scores after counseling. by Shaaista Budhani (21030221)

“…There was a trend of increased recall rates in group 2 for short-term problems, long-term problems, intervention, and incidence rates, but it did not reach statistically significant level. …”

Data. by Aroon La-up (14095691)

“…However, no statistically significant changes were observed in groups with U-Cd levels above 2.0 μg/g creatinine. …”

Change in Mean Anxiety Scores Over time by group. by Shaaista Budhani (21030221)

“…There was a trend of increased recall rates in group 2 for short-term problems, long-term problems, intervention, and incidence rates, but it did not reach statistically significant level. …”

Distribution of final population size (A) and mean change in mean MSI over time (B) over 100 simulations for each parameter set shown in Table 3 in the absence of weevils (left) an... by Alexandra M. Campbell (3284094)

Changes in AL (A) and SE (B) according to the treatment time estimation curve in patients given 0.125% atropine. by Zi-Rong Chen (9227618)

Subjects:

Flow diagram of the patient selection into the final analysis. by Zi-Rong Chen (9227618)

Subjects:

Patients’ demographics and clinical parameters. by Zi-Rong Chen (9227618)

Subjects:

Associations between demographic variables, In4_SED and SE changes at 6 and 12 months after 4_SED (<i><i>n</i></i> = 80). by Zi-Rong Chen (9227618)

Subjects:

Table 2 - Early identification of the efficacy of 0.125% atropine treatment for children with Myopia: A prospective pilot study by Zi-Rong Chen (9227618)

Subjects:

Baseline characteristics. by Neng Pan (5262032)

“…No significant changes were observed in the control group.…”

Data ste. by Neng Pan (5262032)

“…No significant changes were observed in the control group.…”

Comparison of post-experimental outcome measures. by Neng Pan (5262032)

“…No significant changes were observed in the control group.…”

Unsupervised hierarchical clustering for BC samples only. by Jinho Lee (587173)

Subjects:

Unsupervised hierarchical clustering for benign samples only (nontreatment, STT, and LTT groups). by Jinho Lee (587173)

Subjects: